Evidence map›Paper›PMID 23060450›Full record

Trial reportThe Journal of biological chemistry2012

Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.

Victoria J Hammond, Alwena H Morgan, Sarah Lauder, Christopher P Thomas, Sarah Brown, Bruce A Freeman, Clare M Lloyd, Jane Davies, Andrew Bush, Anna-Liisa Levonen and 7 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Protein Lipoxidation: Basic Concepts and Emerging Roles.Antioxidants (Basel, Switzerland) · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Phospholipid signaling in innate immune cells.The Journal of clinical investigation · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Victoria J HammondSchool of Medicine, Cardiff University, Heath Park Campus, Cardiff CF14 4XN, United Kingdom.
Alwena H Morgan
Sarah Lauder
Christopher P Thomas
Sarah Brown
Bruce A Freeman
Clare M Lloyd
Jane Davies
Andrew Bush
Anna-Liisa Levonen
Emilia Kansanen
Luis Villacorta
Y Eugene Chen
Ned Porter
Yoel M Garcia-Diaz
Francisco J Schopfer
Valerie B O'Donnell
University of Pittsburgh · USImperial College London · GBCardiff University · GBUniversity of Eastern Finland · FIUniversity of Michigan–Ann Arbor · USVanderbilt University · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Translational StudiesP30DK072506 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PILEWSKI, JOSEPH MARK · 2005 to 2017
$12.5M
The Role of PPAR-gamma in Vascular Lesion FormationR01HL068878 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2002 to 2019
$7.6M
Redox-Derived Pulmonary Anti-Inflammatory MediatorsR01HL064937 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 2000 to 2015
$5.6M
NITRIC OXIDE REGULATION OF VASCULAR OXIDANT INJURYR01HL058115 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 1998 to 2007
$3.3M
Nitro-Fatty Acids and Nrf2 in Vascular RemodelingR01HL105114 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2010 to 2014
$2.6M
Nitroalkenes and Blood Pressure RegulationR01HL089544 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2008 to 2012
$2.0M
Formation of Omega 3-Derived Electrophiles During InflammationR01AT006822 · NCCIH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHOPFER, FRANCISCO JOSE · 2011 to 2015
$1.8M
NCCIH NIH HHS R01 AT006822NCCIH NIH HHS R01-AT006822-01NHLBI NIH HHS HL068878 ANHLBI NIH HHS HL89544NHLBI NIH HHS P01 HL103455NHLBI NIH HHS P01-HL103455NHLBI NIH HHS R01 HL058115NHLBI NIH HHS R01-HL058115NHLBI NIH HHS R01 HL064937NHLBI NIH HHS R01 HL068878NHLBI NIH HHS R01 HL089544NHLBI NIH HHS R01 HL105114NHLBI NIH HHS R01-HL64937NIDDK NIH HHS P30 DK072506NIDDK NIH HHS P30-DK072506Wellcome Trust 087618
6 · The paper itself

Abstract

12/15-Lipoxygenases (LOXs) in monocytes and macrophages generate novel phospholipid-esterified eicosanoids. Here, we report the generation of two additional families of related lipids comprising 15-ketoeicosatetraenoic acid (KETE) attached to four phosphatidylethanolamines (PEs). The lipids are generated basally by 15-LOX in IL-4-stimulated monocytes, are elevated on calcium mobilization, and are detected at increased levels in bronchoalveolar lavage fluid from cystic fibrosis patients (3.6 ng/ml of lavage). Murine peritoneal macrophages generate 12-KETE-PEs, which are absent in 12/15-LOX-deficient mice. Inhibition of 15-prostaglandin dehydrogenase prevents their formation from exogenous 15-hydroxyeicosatetraenoic acid-PE in human monocytes. Both human and murine cells also generated analogous hydroperoxyeicosatetraenoic acid-PEs. The electrophilic reactivity of KETE-PEs is shown by their Michael addition to glutathione and cysteine. Lastly, both 15-hydroxyeicosatetraenoic acid-PE and 15-KETE-PE activated peroxisome proliferator-activated receptor-γ reporter activity in macrophages in a dose-dependent manner. In summary, we demonstrate novel peroxisome proliferator-activated receptor-γ-activating oxidized phospholipids generated enzymatically by LOX and 15-prostaglandin dehydrogenase in primary monocytic cells and in a human Th2-related lung disease. The lipids are a new family of bioactive mediators from the 12/15-LOX pathway that may contribute to its known anti-inflammatory actions in vivo.

Indexed as

AnimalsArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseArachidonic AcidsCystic FibrosisFemaleHumansMacrophages, AlveolarMacrophages, PeritonealMaleMiceMonocytesPhosphatidylethanolaminesPPAR gammaArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseArachidonic AcidsPhosphatidylethanolaminesPPAR gamma

Identifiers

PMID23060450
PMCPMC3516716
OpenAlexW2136072767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.